| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |